Category1 Category2 Category3

The private equity firm bought the nutritional supplement maker using debt as leverage in 2010 and could potentially sell it now for $6 billion.

ID:http://www.nytimes.com/2017/02/01/business/dealbook/healthy-payout-possible-for-carlyle-from-natures-bounty.html_0